Skip to main content
Erschienen in: The Journal of Obstetrics and Gynecology of India 6/2019

23.11.2019 | Guest Editorial

Coagulopathies in Pregnancy: What an Obstetrician Ought to Know!

verfasst von: Abhay A. Bhave

Erschienen in: The Journal of Obstetrics and Gynecology of India | Ausgabe 6/2019

Einloggen, um Zugang zu erhalten

Excerpt

It is a matter of concern if you read “33 women die every hour from pregnancy and childbirth complications - India among 10 nations with highest maternal mortality ratio” (WHO). Complications of pregnancy and childbirth are the leading causes of disability and death amongst women between the ages of 15 and 49. In a study conducted in Mumbai, more than half of the women suffer from various complications and were in the younger age hailing from rural areas [1]. …
Literatur
1.
Zurück zum Zitat Gogoi M. Pregnancy complications and birth outcome: do health care services make a difference? Int Res J Soc Sci. 2015; 4(3):27–35. Gogoi M. Pregnancy complications and birth outcome: do health care services make a difference? Int Res J Soc Sci. 2015; 4(3):27–35.
2.
Zurück zum Zitat Bolte AC, Hermans FJ, Van Rheenen-Flach LE. [227-POS]: Thromboelastography (TEG®) and rotational thromboelastometry (ROTEM®) in pregnancy: a systematic review. Pregnancy Hypertens Int J Women's Cardiovascular Health.. 2015;5(1):114–5. Bolte AC, Hermans FJ, Van Rheenen-Flach LE. [227-POS]: Thromboelastography (TEG®) and rotational thromboelastometry (ROTEM®) in pregnancy: a systematic review. Pregnancy Hypertens Int J Women's Cardiovascular Health.. 2015;5(1):114–5.
3.
Zurück zum Zitat Levi M. Disseminated intravascular coagulation (DIC) in pregnancy and the peri-partum period. Thromb Res. 2009;1(123):S63–S6464.CrossRef Levi M. Disseminated intravascular coagulation (DIC) in pregnancy and the peri-partum period. Thromb Res. 2009;1(123):S63–S6464.CrossRef
4.
Zurück zum Zitat Erez O, Mastrolia SA, Thachil J. Disseminated intravascular coagulation in pregnancy: insights in pathophysiology, diagnosis and management. Am J Obstet Gynecol. 2015;213(4):452–63.CrossRef Erez O, Mastrolia SA, Thachil J. Disseminated intravascular coagulation in pregnancy: insights in pathophysiology, diagnosis and management. Am J Obstet Gynecol. 2015;213(4):452–63.CrossRef
5.
Zurück zum Zitat Cortet M, Deneux-Tharaux C, Dupont C, Colin C, Rudigoz RC, Bouvier-Colle MH, Huissoud C. Association between fibrinogen level and severity of postpartum haemorrhage: secondary analysis of a prospective trial. Br J Anaesth. 2012;108(6):984–9.CrossRef Cortet M, Deneux-Tharaux C, Dupont C, Colin C, Rudigoz RC, Bouvier-Colle MH, Huissoud C. Association between fibrinogen level and severity of postpartum haemorrhage: secondary analysis of a prospective trial. Br J Anaesth. 2012;108(6):984–9.CrossRef
6.
Zurück zum Zitat Gupta M, Feinberg BB, Burwick RM. Thrombotic microangiopathies of pregnancy: differential diagnosis. Pregnancy hypertension. 2018;1(12):29–34.CrossRef Gupta M, Feinberg BB, Burwick RM. Thrombotic microangiopathies of pregnancy: differential diagnosis. Pregnancy hypertension. 2018;1(12):29–34.CrossRef
8.
Zurück zum Zitat American College of Obstetricians and Gynecologists. Task Force on Hypertension in Pregnancy Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ task force on hypertension in pregnancy. Obstet Gynecol. 2013 Nov;122(5):1122–31. American College of Obstetricians and Gynecologists. Task Force on Hypertension in Pregnancy Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ task force on hypertension in pregnancy. Obstet Gynecol. 2013 Nov;122(5):1122–31.
9.
Zurück zum Zitat Furlan M, Robles R, Solenthaler M, Wassmer M, Sandoz P, Lämmle B. Deficient activity of von Willebrand factor–cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura. Blood. 1997;89(9):3097–103.CrossRef Furlan M, Robles R, Solenthaler M, Wassmer M, Sandoz P, Lämmle B. Deficient activity of von Willebrand factor–cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura. Blood. 1997;89(9):3097–103.CrossRef
10.
Zurück zum Zitat Peyvandi F, Lavoretano S, Palla R, Feys HB, Vanhoorelbeke K, Battaglioli T, Valsecchi C, Canciani MT, Fabris F, Zver S, Réti M. ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission. Haematologica. 2008; 93(2):232–9.CrossRef Peyvandi F, Lavoretano S, Palla R, Feys HB, Vanhoorelbeke K, Battaglioli T, Valsecchi C, Canciani MT, Fabris F, Zver S, Réti M. ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission. Haematologica. 2008; 93(2):232–9.CrossRef
11.
Zurück zum Zitat Benhamou Y, Baudel JL, Wynckel A, Galicier L, Azoulay E, Provôt F, Pène F, Mira JP, Presne C, Poullin P, Halimi JM. Are platelet transfusions harmful in acquired thrombotic thrombocytopenic purpura at the acute phase? Experience of the French thrombotic microangiopathies reference center. Am J Hematol. 2015;90(6):E127–E129129.CrossRef Benhamou Y, Baudel JL, Wynckel A, Galicier L, Azoulay E, Provôt F, Pène F, Mira JP, Presne C, Poullin P, Halimi JM. Are platelet transfusions harmful in acquired thrombotic thrombocytopenic purpura at the acute phase? Experience of the French thrombotic microangiopathies reference center. Am J Hematol. 2015;90(6):E127–E129129.CrossRef
12.
Zurück zum Zitat N. James, A.C. George, Acquired TTP: Clinical Manifestations and Diagnosis, in: L.L. Leung(Ed.), UpToDate,UpToDate,Waltham, MA, 2017. Accessed on 22 Nov 2017 N. James, A.C. George, Acquired TTP: Clinical Manifestations and Diagnosis, in: L.L. Leung(Ed.), UpToDate,UpToDate,Waltham, MA, 2017. Accessed on 22 Nov 2017
13.
Zurück zum Zitat Bruel A, Kavanagh D, Noris M, Delmas Y, Wong EK, Bresin E, Provôt F, Brocklebank V, Mele C, Remuzzi G, Loirat C. Hemolytic uremic syndrome in pregnancy and postpartum. Clin J Am Soc Nephrol. 2017;12(8):1237–47.CrossRef Bruel A, Kavanagh D, Noris M, Delmas Y, Wong EK, Bresin E, Provôt F, Brocklebank V, Mele C, Remuzzi G, Loirat C. Hemolytic uremic syndrome in pregnancy and postpartum. Clin J Am Soc Nephrol. 2017;12(8):1237–47.CrossRef
14.
Zurück zum Zitat Chan WS, Lee A, Spencer FA, Chunilal S, Crowther M, Wu W, Johnston M, Rodger M, Ginsberg JS. D-dimer testing in pregnant patients: towards determining the next ‘level’ in the diagnosis of deep vein thrombosis. J Thromb Haemost. 2010;8(5):1004–111.PubMed Chan WS, Lee A, Spencer FA, Chunilal S, Crowther M, Wu W, Johnston M, Rodger M, Ginsberg JS. D-dimer testing in pregnant patients: towards determining the next ‘level’ in the diagnosis of deep vein thrombosis. J Thromb Haemost. 2010;8(5):1004–111.PubMed
15.
Zurück zum Zitat Kuriya A, Piedimonte S, Spence AR, Czuzoj-Shulman N, Kezouh A, Abenhaim HA. Incidence and causes of maternal mortality in the USA. J Obstet Gynaecol Res. 2016;42(6):661–8.CrossRef Kuriya A, Piedimonte S, Spence AR, Czuzoj-Shulman N, Kezouh A, Abenhaim HA. Incidence and causes of maternal mortality in the USA. J Obstet Gynaecol Res. 2016;42(6):661–8.CrossRef
16.
Zurück zum Zitat Leonhardt G, Gaul C, Nietsch HH, Buerke M, Schleussner E. Thrombolytic therapy in pregnancy. J Thromb Thrombolysis. 2006;21(3):271–6.CrossRef Leonhardt G, Gaul C, Nietsch HH, Buerke M, Schleussner E. Thrombolytic therapy in pregnancy. J Thromb Thrombolysis. 2006;21(3):271–6.CrossRef
17.
Zurück zum Zitat Forestier F, Daffos F, Capella-Pavlovsky M. Low molecular weight heparin (PK 10169) does not cross the placenta during the second trimester of pregnancy study by direct fetal blood sampling under ultrasound. Thromb Res. 1984;34(6):557–60.CrossRef Forestier F, Daffos F, Capella-Pavlovsky M. Low molecular weight heparin (PK 10169) does not cross the placenta during the second trimester of pregnancy study by direct fetal blood sampling under ultrasound. Thromb Res. 1984;34(6):557–60.CrossRef
18.
Zurück zum Zitat Kamel H, Navi BB, Sriram N, Hovsepian DA, Devereux RB, Elkind MS. Risk of a thrombotic event after the 6-week postpartum period. N Engl J Med. 2014;370(14):1307–15.CrossRef Kamel H, Navi BB, Sriram N, Hovsepian DA, Devereux RB, Elkind MS. Risk of a thrombotic event after the 6-week postpartum period. N Engl J Med. 2014;370(14):1307–15.CrossRef
19.
Zurück zum Zitat Blondon M, Casini A, Hoppe KK, Boehlen F, Righini M, Smith NL. Risks of venous thromboembolism after cesarean sections: a meta-analysis. Chest. 2016;150(3):572–96.CrossRef Blondon M, Casini A, Hoppe KK, Boehlen F, Righini M, Smith NL. Risks of venous thromboembolism after cesarean sections: a meta-analysis. Chest. 2016;150(3):572–96.CrossRef
Metadaten
Titel
Coagulopathies in Pregnancy: What an Obstetrician Ought to Know!
verfasst von
Abhay A. Bhave
Publikationsdatum
23.11.2019
Verlag
Springer India
Erschienen in
The Journal of Obstetrics and Gynecology of India / Ausgabe 6/2019
Print ISSN: 0971-9202
Elektronische ISSN: 0975-6434
DOI
https://doi.org/10.1007/s13224-019-01290-8

Weitere Artikel der Ausgabe 6/2019

The Journal of Obstetrics and Gynecology of India 6/2019 Zur Ausgabe

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.